Epidermal Sensors for Wireless and Enhanced Amputee Skin Tracking (E-SWEAT) Part 1
2 other identifiers
interventional
16
1 country
1
Brief Summary
The goal of this clinical trial is to 1) demonstrate the feasibility of monitoring pressure, temperature, and lactic acid density of sweat inside the prosthetic socket, and 2) verify the relationship between mechanical pressure and Lactic acid density of sweat for lower limb amputees among transtibial amputees. The main questions it aims to answer are:
- Is it feasible to reliably monitor pressure, temperature, and lactic acid density inside the prosthetic sockets simultaneously?
- Will the lactic acid density increase with higher pressure exposure? The participants are expected to wear the newly developed E-SWEAT system on their residual limb and are exposed to two activities, walk which generate mechanical load on the residual limb, and a yoga post - birddog, which does not generate mechanical loading on the residual limb. The E-SWEAT will measure pressure, temperature, and lactic acid density of sweat during these tasks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Sep 2025
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2025
CompletedStudy Start
First participant enrolled
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
October 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2029
October 14, 2025
October 1, 2025
2.9 years
September 11, 2025
October 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lactic acid density
amount of lactic acid in sweat
periprocedural in the first visit
Secondary Outcomes (2)
Socket environment - temperature
periprocedural in the first visit
Socket environment - pressure
periprocedural in the first visit
Other Outcomes (1)
Body weight
At the beginning of the first visit
Study Arms (2)
Normal walking
EXPERIMENTALParticipants walk on a treadmill with user preferred speed.
No load excise - Yuga post
ACTIVE COMPARATORParticipants conduct a yuga post which involves their efforts but not load on their residual limbs
Interventions
Participants conduct a yuga post which involves their efforts but not load on their residual limbs
Mounting the E\_SWEAT sensor to monitor the lactic density, pressure, and temperature inside the socket
Eligibility Criteria
You may qualify if:
- Be 18 years or older
- Have a unilateral lower limb amputee (below the knee). The tibial length on the residual limb must be greater than half of the length of the tibial on the unaffected side
- Have an amputation that occurred over 2 years ago
- Have at least 1 year of experience using your prosthetic leg
- Have used the current socket for at least 6 months without a significant skin issue or major modification
- Be able to comfortably walk 6 mins (with prosthetic legs) without pausing to rest
- Be willing to come to North Carolina State University's Centennial Campus to participate in research and be photographed while doing research activities
You may not qualify if:
- Have a cognitive or visual impairment that affects the participant's ability to provide informed consent or to follow simple instructions during the experiments
- Have any neuropathy observed on the residual limb
- Experience numbness, tingling, muscle weakness, and/or pain in your residual limb
- Weigh more than 300lbs
- Do not want to take photos
- Are pregnant or plan to get pregnant
- Are allergic to latex, which is often contained in medical tapes.
- If you are using medication to control sweat on your residual limb, and your medical provider does not think that it is OK to avoid these medications for 48 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Engineering Build III
Raleigh, North Carolina, 27695, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 11, 2025
First Posted
October 14, 2025
Study Start
September 16, 2025
Primary Completion (Estimated)
July 30, 2028
Study Completion (Estimated)
July 30, 2029
Last Updated
October 14, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
All data will be coded with an ID, which randomly generated.